Advances in Therapy

, Volume 21, Issue 3, pp 178–185 | Cite as

In vitro and ex vivo antioxidant activities of labetalol on rabbit neutrophil respiratory burst

  • Ferdinand Kouoh
  • Bernard Gressier
  • Thierry Dine
  • Michel Luyckx
  • Claude Brunet
  • Louis Ballester
  • Jean Claude Cazin
  • Bernard Gressier


The beta-adrenoreceptor blocker labetalol has demonstrated important antioxidant properties in vitro that inhibit superoxide anion production during normal leukocyte oxidative metabolism. This study investigated the in vitro and ex vivo effects of labetalol on respiratory burst in rabbit neutrophils. The production of superoxide anions was examined in activated purified rabbit neutrophils after intravenous administration of labetalol (4.0 mg/ kg of body weight). At a concentration up to 200 mg/L, labetalol did not demonstrate any cytotoxic effects on neutrophils, as determined by enzyme lactate dehydrogenase activity. In the cell-free system, labetalol demonstrated no significant activity, but in formyl-methionylleucyl-phenylalanine (fMLP)-stimulated rabbit neutrophils, labetalol demonstrated concentration-dependent antioxidant activity. The in vitro 50% inhibitory concentration (IC50) with the fMLP stimulus was 16.5±0.21 mg/L in the rabbit neutrophils and 13.2∓0.16 mg/L in the human neutrophils. In thefMLP-stimulated rabbit polymorphonuclear leukocytes, labetalol demonstrated its peak inhibitory activity (47%) 3 hours after administration. The mechanism by which labetalol acts in the treatment of hypertension may occur from an interaction in the signaling pathway of protein kinase C activation. The antioxidant properties demonstrated in this mechanism contribute to the drug’s antihypertensive action and thus, may reduce the risk of injuries inflicted by reactive oxygen species involved in the pathogenesis of hypertension.


respiratory burst superoxide anion neutrophil in vitro ex vivo antioxidant 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Varon J, Marik PE. The diagnostic and management of hypertension crises.Chest. 2000;118:214–227.PubMedCrossRefGoogle Scholar
  2. 2.
    Kristal B, Shurtz-Swirski R, Chezar J, et al. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patient with essential hypertension.Am J Hypertens. 1998;11:921–928.PubMedCrossRefGoogle Scholar
  3. 3.
    Roos D. The respiratory burst of phagocytic leucocytes.Drug Invest. 1991;3:48–58.Google Scholar
  4. 4.
    Weiss SJ. Tissue destruction by neutrophils.New Engl J Med. 1989;320:365–376.PubMedCrossRefGoogle Scholar
  5. 5.
    Niwa Y. Oxidative injury and its defense in vivo.Rinsho Byori-Japanese J Clin Pathol. 1999;47: 189–209.Google Scholar
  6. 6.
    Jaboureck-Bouttier R, Gressier B, Dine T, et al. Effects of two antihypertensive agents, labetalol and metoprolol, on the production of reactive oxygen species by normal polynuclear leukocytes in vitro.Hypertens Pregnancy. 1999;18:239–247.PubMedCrossRefGoogle Scholar
  7. 7.
    Laurent F, Benoleil AM. Oxidative metabolism of polymorphonuclear leukocytes: modulation by adhesive stimuli.J Leuk Biol. 1991;49:217–226.Google Scholar
  8. 8.
    Tscharner von V. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration.Nature. 1986;324:369–372.CrossRefGoogle Scholar
  9. 9.
    Kessels RGC, Ross D, Verhoeven A.J. F-Met-Leu-Phe-induced activation of phospholipase D in human neutrophils.J Biol Chem. 1991;266:23152–23156.PubMedGoogle Scholar
  10. 10.
    Weisdorf DJ, Thayer MS. Occult intracellular calcium pools: relevance to neutrophil oxidant production.J Lab Clin Med. 1989;114:260–265.PubMedGoogle Scholar
  11. 11.
    Semplicini A, Pessina AC, Rossi GP, et al. Use of labetalol in the treatment of hypertension crises.G Ital Cardiol. 1982;12:355–358.PubMedGoogle Scholar
  12. 12.
    Morel DR, Forster A, Suter PM. Labetalol in the treatment of hypertension following coronaryartery surgery.British Journal of Anaesthesia. 1982;54:1191–1196.PubMedCrossRefGoogle Scholar
  13. 13.
    Fagan SC, Bowes MP, Lyden PD, Zivin JA. Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol.Exp Neurol. 1998;150:153–158.PubMedCrossRefGoogle Scholar
  14. 14.
    Bartsch W, Sponer G, Strein K, Bohm E, Hooper RG. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigation with carvedilol, prazosin, labetalol, and guanethidine.J Cardivasc Pharmacol. 1987;10:S49-S51.CrossRefGoogle Scholar
  15. 15.
    Kouoh F, Gressier B, Luyckx M, et al. A simple method for isolating human and rabbit polymorphonuclear neutrophils (PMNs).Biol Pharm Bull. 2000;23:1382–1383.PubMedGoogle Scholar
  16. 16.
    Levert H, Gressier B, Brunet C, et al. Time and concentration dependent influence of dirithromycin on neutrophils oxidative burst.J Antibiot. 1999;52:127–133.PubMedGoogle Scholar
  17. 17.
    Cohen HJ and Chovaniec RE. Superoxide generation by digitonin stimulated guinea pig granulocytes. A basis for continuous assay for monitoring superoxide production and for the study of the activation of generation system.J Clin Invest. 1978;61:1081–1087.PubMedCrossRefGoogle Scholar
  18. 18.
    Aruoma O, Halliwell B, Hoey BM and Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxil radical, superoxide anion and hypochlorous acid.Free Radical Biol Med. 1989;6:593–597.CrossRefGoogle Scholar
  19. 19.
    Recordati G, Zorzoli F, Pontara O, Turolo L, Zanchetti A. Factors influencing acute ischaemiainduced renal hypertension in rats.J Hypertens. 2002;20:2453–2463.PubMedCrossRefGoogle Scholar
  20. 20.
    Taddei A, Virdis L, Ghiadoni A, Magagna A and Salvetti A. Vitamin C improves endotheliumdependent vasodilation by restoring nitric oxide activity in essential hypertension.Circulation. 1998;97:2222–2229.PubMedGoogle Scholar
  21. 21.
    Vaziri ND, Wang XQ, Oveisi F and Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rat.Hypertension. 2000;36:142–146.PubMedGoogle Scholar
  22. 22.
    Sozmen EY, Kerry Z, Uysal F, et al. Antioxidant enzyme activities and total nitite/nitate levels in the collar model. Effect of nicardipine.Clin Chem Lab Med. 2000;38:21–25.PubMedCrossRefGoogle Scholar
  23. 23.
    Haffner SM. Clinical relevance of the oxidative stress concept.Metabolism. 2000;49:30–34.PubMedCrossRefGoogle Scholar
  24. 24.
    Kouoh F, Gressier B, Dine T, et al. Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils-A potential antiatherosclerotic property of calcium antagonist?Cardiovasc Drug Ther. 2002;16:515–520.CrossRefGoogle Scholar
  25. 25.
    Chin BS, Langford NJ, Nuttall SL, Gibbs CR, Blann AD, Lip GY. Antioxidative properties of betablockers and angiotensin-converting enzyme inhibitors in congestive heart failure.Eur J Heart Fail. 2003;5:171–174.PubMedCrossRefGoogle Scholar
  26. 26.
    Kano J, Allomen H, Kleimola T. Pharmacokinetics of labetalol in healthy volunteers.Int J Clin Pharmacol Ther Toxico. 1981;19:41–44.Google Scholar
  27. 27.
    Shimpo K, Fujiwara S, Katada H, Togashi H, Yokoi Y, Tanabe T. On the acute toxicity of labetalol (AH-5158), a combined alpha-and-beta-adrenoceptor-blocking agent.Hokkaido Igaku Zasshi. 1978; 53:15–21.PubMedGoogle Scholar
  28. 28.
    World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guideline subcommittee.J Hypertens. 1999;17:151–183.Google Scholar

Copyright information

© Health Communications Inc 2004

Authors and Affiliations

  • Ferdinand Kouoh
    • 1
  • Bernard Gressier
    • 1
  • Thierry Dine
    • 1
  • Michel Luyckx
    • 1
  • Claude Brunet
    • 1
  • Louis Ballester
    • 1
  • Jean Claude Cazin
    • 1
  • Bernard Gressier
    • 2
  1. 1.Faculty of Biological and Pharmaceutical SciencesLaboratory of Pharmacology Pharmacokinetic and Clinical PharmacyFrance
  2. 2.Faculty of PharmacyLaboratory of PharmacologyAmiens CedexFrance

Personalised recommendations